|
TBPH Theravance Biopharma Inc 1583107 |
| Balance Sheet |
|
Current Assets
|
161,067,000 |
|
Assets
|
354,161,000 |
|
Current Liabilities
|
32,085,000 |
|
Liabilities
|
178,616,000 |
|
Equity
|
175,545,000 |
|
Shares Out
|
48,922,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-11,535,000 |
|
Investing Cash Flow
|
12,284,000 |
| Market Analysis |
Market Cap
|
423,175,886 |
|
Price
|
9.38 |
|
BVPS
|
3.59 |
|
PB
|
2.63 |
|
EPS
|
-0.92 |
|
PS
|
5.64 |
|
FCF
|
749,000 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/26 |
-0.17 |
3/7 |
-0.31 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TBPH documents filed with the SEC.
TBPH Filings
Clear
